What Is Quality by Design?. Quality by Design: QbD Defined Prospectively examining the objectives of a trial and defining factors critical to meeting.

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

1 Managing Authority Conducting a self assessment 10 June 2008 A. Badrichani – DG Regional Policy – Audit Unit J3.
Analysis of Electronic Medical Record Systems Jonathan S. Schildcrout.
Strengthening the Medical Device Clinical Trial Enterprise
1 The critical challenge facing banks and regulators under Basel II: improving risk management through implementation of Pillar 2 Simon Topping Hong Kong.
Elements of a clinical trial research protocol
A Review of the Draft Principles Document Establishing the context Ann Meeker-O’Connell.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
David A. Gerber, MD Professor and Chief Division of Abdominal Transplantation Department of Surgery University of North Carolina at Chapel Hill.
Title slide PIPELINE QRA SEMINAR. PIPELINE RISK ASSESSMENT INTRODUCTION TO GENERAL RISK MANAGEMENT 2.
Performance Monitoring All All Contracts require basic monitoring once awarded. The Goal of contract monitoring is to ensure that the contract is satisfactorily.
Frequently Asked Questions (FAQ) prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
A Safety Management System (SMS) is: “A systematic approach to managing safety, including the necessary organizational structures, accountabilities,
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Basics of OHSAS Occupational Health & Safety Management System
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Mixed Methods and Other Special Types of Research.
Performance Measurement and Analysis for Health Organizations
Module 3. Session DCST Clinical governance
1 Accreditation and Certification: Definition  Certification: Procedures by which a third party gives written assurance that a product, process or service.
Building Quality Assurance into Clinical Trials. Objectives for Today: Define Quality in Research Describe How to Initiate Corrective and Preventative.
Integrating Safety Management Systems – Opportunities for Improvement
Advancing Quality in Primary Care – What is Quality Improvement? 10 March 2011 Powys THB/IRH Paul Myres- Chair Primary Care Quality Forum.
Systematic Reviews.
UNEP Training Resource Manual Topic 11 Slide 1 Aims of EIA implementation and follow up are to: F carry out conditions of approval F ensure they work effectively.
So You Want to Do CDS A C-Level Introduction to Clinical Decision Support.
QUALITY RISK MANAGEMENT RASHID MAHMOOD MSc. Analytical Chemistry MS in Total Quality Management Senior Manager Quality Assurance Nabiqasim Group of Industries.
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
Risk Management & Corporate Governance 1. What is Risk?  Risk arises from uncertainty; but all uncertainties do not carry risk.  Possibility of an unfavorable.
FACILITATOR Prof. Dr. Mohammad Majid Mahmood Art of Leadership & Motivation HRM – 760 Lecture - 25.
EXPERIMENTAL EPIDEMIOLOGY
9. Applying scientific tools & techniques for improving customer satisfaction.
Molecule-to-Market-Place Quality
Implementation and follow up Critically important but relatively neglected stages of EIA process Surveillance, monitoring, auditing, evaluation and other.
Agenda for Session Compliance in Clinical Research
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Environment and Disaster Planning Hari Srinivas, GDRC Rajib Shaw, Kyoto University Contents of the presentation: -What is the problem? -Precautionary Principles.
Aligning Ethics Communication & Training With Business Priorities and Compliance Risks Willow Misty Parks Graduate Assistant Anderson School of Management.
Why So Much Attention on Rubric Quality? CAEP Standard 5, Component 5.2: The provider’s quality assurance system relies on relevant, verifiable, representative,
Introduction to Research. Purpose of Research Evidence-based practice Validate clinical practice through scientific inquiry Scientific rational must exist.
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
Office of Human Research Protection Georgia Health Sciences University.
Quality Improvement: Overview of Principles and Techniques
Learning Outcomes Discuss current trends and issues in health care and nursing. Describe the essential elements of quality and safety in nursing and their.
Erman Taşkın. Information security aspects of business continuity management Objective: To counteract interruptions to business activities and to protect.
Strengthening Research Capabilities Professor John B. Kaneene DVM, MPH, PhD, FAES, FAVES Center for Comparative Epidemiology Michigan State University.
CBIZ RISK & ADVISORY SERVICES BUSINESS CONTINUITY PLANNING Developing a Readiness Strategy that Mitigates Risk and is Actionable and Easy to Implement.
RISK MANAGEMENT FOR COMMUNITY EVENTS. Today’s Session Risk Management – why is it important? Risk Management and Risk Assessment concepts Steps in the.
Methods: The project used a mixed methods approach including qualitative focus groups, a questionnaire study and systematic searches of the research literature.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
Context and Problem Effects of Changes Strategy for Change Aim: To reduce the length of handover by standardising the quality of information transmitted.
GCP (GOOD CLINICAL PRACTISE)
PRAGMATIC Study Designs: Elderly Cancer Trials
Issues that Matter Notification and Escalation
CLINICAL TRIALS.
DATA COLLECTION METHODS IN NURSING RESEARCH
Patient Focused Drug Development An FDA Perspective
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
CONDUCTING THE TRIAL AT
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
Data Managers’ Forum What’s in it for us?
Good Clinical Practice
Performance Improvement Project Validation Process Outcome Focused Scoring Methodology and Critical Analysis Presenter: Christi Melendez, RN, CPHQ Associate.
UK Legal Requirement for Notification of Serious Breaches of Good Clinical Practice or The Trial Protocol John Poland, PhD Senior Director, Regulatory.
HUMAN RESOURCE GOVERNANCE, RISK MANAGEMENT AND COMPLIANCE
Crucial Statistical Caveats for Percutaneous Valve Trials
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
Quality Assurance in Clinical Trials
Presentation transcript:

What Is Quality by Design?

Quality by Design: QbD Defined Prospectively examining the objectives of a trial and defining factors critical to meeting these objectives Understanding what data and processes underpin a successful trial is essential to subsequently identifying and managing important and likely risks to improve quality and outcomes for clinical trials … taking action to prevent important risks to these critical factors from negatively impacting outcomes … focusing effort on those “errors that matter” for the success of the clinical trial “Quality” in clinical trials is defined as the absence of errors that matter

How QbD Improves Clinical Trials Protect patients during the trial Obtain reliable results and meaningful information from the trial QbD helps organizations become prospectively and fully aware throughout the trial lifecycle of the important errors that could jeopardize the ability to …

QbD Step 1 Identify “critical to quality” factors (CTQs) for your specific trial

QbD Step 2 Discuss potential risks related to each CTQ identified that impact study quality (i.e., participant safety or credibility of results)

QbD Step 3 Mitigate those risks that will likely lead to errors that matter and determine how to rapidly identify and react when there is an issue

QbD Implementation Tool: CTTI Principles Document … place subjects at unnecessary risk The Principles document is a resource that facilitates critical thinking and quality planning. It helps organizations gain a clear understanding of events that can … … impede the conduct of the study … hinder efforts to use resulting data to answer the scientific questions being addressed

QbD Implementation: Plan, Do, Check, Act PLAN DO CHECK ACT Build/plan quality into clinical trials from the beginning, focusing on what matters most Implement study risk management strategies Monitor leading indicators of quality in the study Systematically drive remediation and learning

Bringing QbD Into Your Organization Focus on what matters  “Quality” is defined as the absence of errors that matter  Determine what matters for the specific trial Develop a quality management plan  Initiate plan in parallel with protocol development  Focus on areas of highest risk for generating errors that matter Assess performance in important parameters  Prospectively measure error rates of important parameters  Tailor the monitoring approach (e.g., site visits, central, statistical) to the trial design and key quality objectives Improve training and procedures  Base on measured parameters Report findings of quality management approach  Include issues found, actions taken, impact on analysis, and interpretation of results  Incorporate into regulatory submissions and publications

Use the QbD Toolkit